Daily enterprise tech brief ·
Enterprise AI releases: 26 October 2026
What changed. Why it matters to your business. What to test.
Lead signals
Research Hub ↗Tempus Secures $192.5 Million R&D Agreements
What's new: Tempus disclosed $192.5 million in agreements covering BMS oncology data and Lens access, plus Pathos neurology records and Tempus Agent licensing.
Drug-development teams can analyze governed de-identified datasets in dedicated AI environments, reducing data integration effort for discovery and clinical-development planning.
Box Audit Logs Reach Lakeflow Connect
What's new: Azure Databricks released a managed Box Audit Logs connector in beta for Lakeflow Connect, ingesting Box enterprise audit events.
Security and compliance teams can centralize Box activity with lakehouse data, reducing custom ingestion work for investigations, reporting, and governance analytics.
Executive summary & decision signals
POC focus: Drug-development teams can analyze governed de-identified datasets in dedicated AI environments, reducing data integration effort for discovery and clinical-development planning.
- Drug-development teams can analyze governed de-identified datasets in dedicated AI environments, reducing data integration effort for discovery and clinical-development planning.
- Security and compliance teams can centralize Box activity with lakehouse data, reducing custom ingestion work for investigations, reporting, and governance analytics.
All source evidence
Practical questions
What enterprise change is described in "Tempus Secures $192.5 Million R&D Agreements"?
Tempus disclosed $192.5 million in agreements covering BMS oncology data and Lens access, plus Pathos neurology records and Tempus Agent licensing.
What enterprise change is described in "Box Audit Logs Reach Lakeflow Connect"?
Azure Databricks released a managed Box Audit Logs connector in beta for Lakeflow Connect, ingesting Box enterprise audit events.
Business implications are editorial assessments, not measured returns. Confirm release status, availability and eligibility before testing.